Efficacy of Internet and Smartphone Application-delivered Tinnitus Retraining Therapy
NCT ID: NCT01663467
Last Updated: 2016-10-25
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2014-09-30
2016-09-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Tinnitus Retraining Therapy Trial
NCT01177137
Randomized Trial Of Tinnitus Retraining Therapy
NCT00578058
The Effect of Tinnitus Retraining Therapy on Subjective and Objective Measures of Chronic Tinnitus
NCT00124800
Study of Application of Transcutaneous Trigeminal Nerve Stimulation and Sound Fusion Stimulation on Tinnitus
NCT05291078
Tinnitus Treatment Using a Smartphone Application
NCT03688113
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Ginkgo biloba only
control group Ginexin-F 80mg tablet will be given twice a day for 6 months.
Ginkgo biloba
Ginexin-F 80mg tablet will be given twice a day for 6 months.
Ginkgo biloba + modified TRT
experimental group modified TRT (tinnitus retraining therapy) using smartphone and web based materials will be added with Ginkgo biloba.
Ginexin-F 80mg tablet will be given twice a day for 6 months.
Ginkgo biloba
Ginexin-F 80mg tablet will be given twice a day for 6 months.
modified TRT
modified TRT (tinnitus retraining therapy) using smartphone and web based materials will be added with Ginkgo biloba.
Ginexin-F 80mg tablet will be given twice a day for 6 months.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Ginkgo biloba
Ginexin-F 80mg tablet will be given twice a day for 6 months.
modified TRT
modified TRT (tinnitus retraining therapy) using smartphone and web based materials will be added with Ginkgo biloba.
Ginexin-F 80mg tablet will be given twice a day for 6 months.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
20 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Soonchunhyang University Hospital
OTHER
Seoul National University Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
YOUNG HO KIM
Associate Professor, Department of Otolaryngology-Head and Neck Surgery, Seoul National University College of Medicine, Seoul National University Boramae Medical Center
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
YOUNG HO KIM, MD., PhD
Role: STUDY_CHAIR
Seoul National University Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Seoul National University Hospital
Seoul, , South Korea
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SNUH_YHK_TRT
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.